Harrow health, inc. (HROW)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

50,692

51,165

49,945

47,929

44,797

41,372

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenues

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

16,477

16,749

17,286

17,416

16,348

16,521

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales, net

-

-

-

-

-

-

-

-

-

-

-

-

21,635

19,927

17,634

15,458

12,473

9,654

6,710

4,467

3,214

1,652

1,103

664

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

License revenues

-

-

-

-

-

-

-

-

-

-

-

-

23

15

18

16

61

62

53

54

7

8

9

10

9

10

7

5

2

100

100

100

100

0

0

0

0

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

21,658

19,942

17,652

15,474

12,534

9,716

6,763

4,521

3,221

1,660

1,112

674

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

10,939

9,831

8,707

7,570

6,448

5,206

3,637

2,674

2,100

1,093

715

476

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Gross profit

34,215

34,416

32,659

30,513

28,449

24,851

21,449

17,981

15,323

13,269

12,111

11,553

10,719

10,111

8,945

7,904

6,086

4,510

3,126

1,847

1,121

567

397

198

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Selling and marketing

-

-

-

-

-

-

-

-

-

-

-

-

-

7,382

8,008

8,024

7,384

6,496

5,357

4,181

3,020

2,390

1,488

851

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

17,569

17,532

15,618

13,964

12,504

10,276

9,126

8,672

8,087

7,760

7,363

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

32,969

33,096

34,411

32,767

31,298

29,243

26,173

24,990

24,696

25,019

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,691

2,980

2,553

1,673

810

827

1,099

1,442

0

0

0

Research and development

2,081

2,083

2,092

1,881

1,143

825

481

311

340

413

925

878

853

739

171

248

197

332

370

347

358

237

180

579

1,220

1,616

2,320

2,154

1,610

1,298

580

276

167

111

254

341

0

0

0

Impairment and disposal of long-lived assets

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

39,090

39,219

40,543

34,648

32,441

30,068

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets and goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

26,921

27,078

25,993

26,014

23,890

21,545

19,332

16,003

13,654

12,050

10,714

9,687

9,119

8,558

7,696

0

0

0

-

-

-

-

-

-

-

-

-

-

Loss from operations

-4,875

-4,803

-7,884

-4,135

-3,992

-5,217

-5,205

-7,320

-9,713

-12,163

-13,520

-15,368

-16,359

-15,882

-17,069

-15,986

-15,459

-14,822

-12,877

-11,807

-10,929

-10,147

-9,290

-8,921

-8,549

-7,686

-7,252

-6,412

-5,299

-4,178

-3,033

-1,849

-877

-939

-1,353

-1,784

0

0

0

Other income (expense):
Interest expense, net

-2,457

-2,500

-2,628

-2,713

-2,668

-2,728

-2,717

-2,805

-2,901

-3,026

-3,130

-3,069

-2,933

-2,774

-2,421

-2,112

-1,730

-1,108

-674

-244

12

29

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

-

-

-

-

-

Debt extinguishment loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-189

-1,195

-1,195

-1,195

-1,006

0

0

26

0

0

0

Change in fair value of derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

113

113

113

113

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment losses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on deconsolidation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of assets

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

Gain on forgiveness of liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

Gain on forgiveness of liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

60

60

0

0

0

-

-

Other expense, net

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29

170

1,204

1,168

1,192

1,023

14

74

47

0

0

0

Other income (expense), net

-

630

375

0

0

-

-

0

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

62

77

75

74

73

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

5

0

0

0

0

0

0

0

Total other (expense) income, net

-19,506

4,678

23,297

28,664

33,463

19,842

-1,922

-3,013

-1,686

-757

-1,991

1,727

-3,377

-3,316

-1,040

-2,225

-1,843

-1,077

-643

-213

43

29

36

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) income before income taxes

0

-

-

-

0

-

-

-

-

-12,920

-15,511

-13,641

-19,736

-19,198

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31

31

31

31

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit, net

-

-

-

-

-

-

-

-

-

-935

-195

-167

-139

-111

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total net (loss) income including noncontrolling interests

-24,381

-125

15,413

24,529

29,471

14,625

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interests

284

293

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income attributable to Harrow Health, Inc.

-24,097

168

15,641

24,596

29,496

14,625

-6,276

-9,454

-10,492

-11,985

-15,316

-13,474

-19,597

-19,087

-18,109

-18,211

-17,302

-15,899

-13,520

-12,020

-10,886

-10,118

-9,255

-8,880

-8,502

-7,643

-7,214

-6,382

-5,469

-5,383

-4,202

-3,041

-1,900

-953

-1,428

-1,831

0

0

0

Basic net (loss) income per share of common stock

-0.50

-

-

-0.09

0.46

-

-

0.12

-0.17

-

-

0.07

-

-

-

-0.35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net (loss) income per share of common stock

-0.50

-

-

-0.09

0.43

-

-

0.11

-0.17

-

-

0.06

-

-

-

-0.35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of shares of common stock outstanding, basic

25,867

-

-

25,216

24,841

-

-

21,190

20,949

-

-

20,209

-

-

-

13,332

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of shares of common stock outstanding, diluted

25,867

-

-

25,216

26,589

-

-

23,175

20,949

-

-

23,177

-

-

-

13,332

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend to preferred stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

200

300

300

100

100

0

0

0

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,669

-5,583

-4,502

-3,341

-2,000

-1,053

0

0

0

-

-

Basic and diluted net loss per share of common stock

-

-

-0.45

-

-

-

-0.12

-

-

-

-0.28

-

-0.26

-

-0.29

-

-0.43

-0.53

-0.41

-0.39

-0.33

-0.30

-0.27

-0.28

-0.26

-0.21

-0.23

-0.25

-0.19

0.65

-0.20

-0.39

-1.30

-2.31

-0.04

-0.08

-0.22

-0.05

-0.03

Weighted average number of shares of common stock outstanding, basic and diluted

-

-

25,583

-

-

-

21,709

-

-

-

20,273

-

18,927

-

13,471

-

10,407

9,862

9,603

9,501

9,337

9,257

9,154

9,109

9,010

8,986

8,961

8,890

7,788

6,816

6,219

3,874

1,063

-

1,987

-

-

-

-

Weighted average common shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,989

1,991

15,859

15,703

Sales, Net [Member]
Total revenues

50,664

51,137

49,916

47,897

44,762

41,334

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License Revenues [Member]
Total revenues

28

28

29

32

35

38

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Melt Pharmaceuticals [Member]
Investment (loss) gain, net

-2,103

3,968

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Surface Pharmaceuticals [Member]
Investment (loss) gain, net

-1,296

-1,200

-1,032

4,586

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Eton Pharmaceuticals [Member]
Investment (loss) gain, net

-13,650

3,780

21,860

26,358

25,562

17,913

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-